Evaxion A EVAX
NASDAQ EVAX
$4.17 +0.12 (+2.96%)
As of: Oct 21, 2026 · 11:28 AM EDT

Evaxion A (EVAX) EBIT Margin (2023 - 2025)

Updated

Evaxion A's EBIT Margin was -122.66% in FY2025, up 317.89 percentage points from -440.55% in FY2024.

Analysis

Evaxion A (EVAX) EBIT Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, EBIT Margin in earlier years was -440.55% in FY2024 (+29966.30 pp) and -30406.85% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,130.87 Bn 1,099.45 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 614.49 Bn 533.02 Bn 17.26 Bn 28.21%
3 AbbVie 502.45 Bn 475.56 Bn 12.70 Bn 37.86%
4 Merck 368.35 Bn 322.73 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.42 Bn 262.41 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.95 Bn 235.64 Bn 12.86 Bn 20.57%
7 Amgen 235.96 Bn 191.36 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.17 Bn 165.37 Bn 6.22 Bn -133.21%
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn 28.37%
10 Evaxion A 27.04 Mn -39.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 40.34%
Jun 30, 2025 -11,729.73%
Dec 31, 2024 -3,298.36%
Sep 30, 2024 -57.37%
Jun 30, 2024 -2,974.68%
Mar 31, 2024 -8,619.61%
Dec 31, 2023 -588.93%
API Access

Evaxion A EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=EVAX&period=max&api_key=YOUR_API_KEY